Overview Fundamentals API Earnings EOD API Sample Code Pricing

Oncternal Therapeutics Inc (ONCT NASDAQ) stock market data APIs

$7.0831 0.08(1.1%) as of July 19, 2024
Price chart is built with Anychart

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors, as well as targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate in preclinical development for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The company has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. is headquartered in San Diego, California.

Oncternal Therapeutics Inc Financial Data Overview

7
7.0831
-
7.0831
7
5.57-13.2
20 717 K
2 960 K
1 151 K
-2.83
1.356
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ONCT',
Type: 'Common Stock',
Name: 'Oncternal Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000BX50F2',
ISIN: NULL,
CUSIP: NULL,
CIK: '1260990',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2004-02-03',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Oncternal Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 151 K
  • EBITDA 0
  • Earnings Per Share -12.33
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Oncternal Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -2.88

Get Oncternal Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com